0
New
New
2022
Hemostats Market

Hemostats Market

by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others), by Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others), by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A16840
Pages: 237
Jun 2022 | 890 Views
Author(s) : Shraddha M , Onkar S
Tables: 164
Charts: 68
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

Hemostats Market Research, 2031

The global hemostats market was valued at $2.8 billion in 2021, and is projected to reach $4.7 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031. Hemostat is referred to a surgical agent that regulates and controls the bleeding process during surgical procedures. Hemostats help to shorten surgery time and reduces the need for blood transfusion. Hemostatic agents are essential in establishing hemostasis in pre-hospital conditions and preventing death associated with hemorrhage. Hemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used in adjunct to surgical procedures to manage bleeding. Hemostatic agents offer different benefits, which include decreased wound healing & operative time, better management of anti-coagulated patients, and reduction in the patient recovery period boosting the hemostasis market.

The growing concerns regarding the spread of the novel COVID-19 pandemic has led a majority of the healthcare systems to postponed or cancelled non-essential medical procedures. Thus, decrease in number of surgical procedures has hindered the hemostats market growth.

Hemostats Market, Hemostasis Market, Hemostasis Product Market, flowable hemostats market, Hemostats Market Size, Hemostats Market Share, Hemostats Market Analysis, Hemostats Market Growth, Hemostats Market Opportunity, Hemostats Market Trends, Hemostats Market Forecast

The growth of the global hemostats market size is majorly driven by increase in number of surgeries such as orthopedic surgery, gynecological surgery, reconstructive surgery, and cardiac surgery; rise in in various cancer types that require surgical procedures; and development of new hemostasis product market by large number of key players. Moreover, rise in flowable hemostats usage boosts the flowable hemostats market. According to the International Osteoporosis Foundation, in 2019, approximately 200 million people were affected by osteoporosis-related fractures across the globe. Thus, rise in burden of orthopedic disorders increases the demand for hemostats to reduce surgical injuries, which is anticipated to foster the growth of the hemostats market size. Furthermore, rise in geriatric population notably contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to various types of diseases, which increases the need for surgeries, thus boosting the hemostats market share. Furthermore, increase in number of road accidents has led to surge in surgical procedures, which augmented the growth of the hemostats market. According to the World Health Organization, in 2019, approximately 235 million major surgical procedures were performed across the globe. According to the National Cancer Statistics, in 2020, there were 1,806,590 new cases of cancer in the U.S. Therefore, surge in number of surgeries is anticipated to boost the growth of the market. According to the American Society of Plastic Surgeons, 15.6 million cosmetic surgeries were performed in 2020. Furthermore, increase in number of product approvals is expected to provide lucrative hemostats market opportunity for the expansion during the hemostats market forecast period. Thus, rise in hemostats utilization in surgeries is bound to increase hemostasis market potential.
The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global hemostats industry. According to the National Library of Medicine, in 2020, there were 1,307 cases of bariatric surgeries reported in India. Out of which 78% were performed before March 31, 2020 and 276 were performed after April 1, 2020. There were 87 patients found to be positive who underwent bariatric surgery. Thus, rise in number of bariatric surgeries has increased the usage of hemostats during surgical procedures, which drives the hemostats market growth.
Moreover, new innovations by key players and rise in number of product approvals propel the growth of the market. However, stringent government regulations associated with the approval of hemostats restrict the hemostats industry growth.

Hemostats Market Segmentation

The hemostats market analysis is segmented into type, formulation, application, and region. By type, the market is categorized into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, collagen-based hemostats, and others. Depending on formulation, it is fragmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, powder hemostats, and others.
On the basis of application, it is segregated into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other surgeries.
    
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

Depending on type, the thrombin-based hemostats segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for use in surgical procedure, and surge in adoption of surgical hemostat instruments. However, the collagen-based hemostats segment is expected to witness considerable growth during the forecast period, owing to increase in number of surgeries and rise in number of key players for development of hemostats in the pharmaceutical industry.
 

Hemostats Market
By Type

Your browser does not support the canvas element.

Thrombin Based Hemostats segment dominated the market in 2021, and is expected to remain dominant during the forecast period

Get more information on this report : Request Sample Pages

By formulation, the matrix & gel hemostats segment was the major contributor in 2021, and is expected to maintain its lead during the forecast period, owing to increase in number of cosmetic surgeries, rise in number of cardiac disorders, and increase in demand for hemostats to reduce surgical injuries. However, the powder hemostats segment is expected to witness considerable growth during the forecast period, due to increase in number of cardiovascular disorders, rise in use during surgical procedure, and development of new surgical products in the hospital.

Hemostats Market
By Formulation

Your browser does not support the canvas element.

Matrix and Gel Hemostats segment dominated the market in 2021, and is expected to remain dominant during the forecast period

Get more information on this report : Request Sample Pages

By application, the orthopedic surgery segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in number of laparoscopic surgeries, rise in number of cardiac disorders, and increase in demand for hemostats or performing surgeries. However, the cardiovascular surgery segment is expected to witness considerable growth during the forecast period due to increase in number of vascular surgeries, rise in use of hemostats during surgical procedure, and development of new surgical hemostats instruments.

Hemostats Market
By Application

Your browser does not support the canvas element.

Orthopedic Surgery segment dominated the market in 2021, and is expected to remain dominant during the forecast period

Get more information on this report : Request Sample Pages

Region wise, North America garnered the major share in the hemostats market in 2021, and is expected to continue to dominate during the forecast period, owing to rise in number of surgeries, presence of key players, development of the healthcare sector, and presence of new innovative hemostats products in the region. However, Asia-Pacific is expected to register the highest CAGR of 7.1% from 2021 to 2031, owing to increase in prevalence of orthopedic diseases led to increase number of surgeries and development of healthcare infrastructure.

Hemostats Market
By Region

2031
North America 
Europe
Asia-pacific
Lamea

North America, dominated the global market in 2021, whereas, Asia-Pacific in anticipated to witness the most notable growth

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hemostats market analysis from 2021 to 2031 to identify the prevailing hemostats market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hemostats market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hemostats market trends, key players, market segments, application areas, and market growth strategies.

Hemostats Market Report Highlights

Aspects Details
By Type
  • Thrombin Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
  • Others
By Formulation
  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats
  • Others
  • Matrix and Gel Hemostats
By Application
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson and Company, Hemostatis LLC, Integra Life Sciences Holding Corporation, Johnson and Johnson, Medtronic Plc, Pfizer Inc., Stryker Corporation, Teleflex Incorporated
 

Loading Table Of Content...


 
 

This section provides the opinions of the top level CXOs in the hemostats market. According to the CXOs, rise in R&D activities in pharmaceutical industry is more likely to drive growth of the market during forecast period. In addition, increase in healthcare expenditure followed by strategic collaborations between key players play crucial role in the growth of the market. 
The CXOs further added that according to WHO estimates (2019), approximately 235 million surgical procedures are undertaken worldwide every year, which fuels the market growth. In addition, rise in number of product approvals propels the market growth. For instance, in 2020, Baxter received an FDA approval for PeriStrips Dry with Veritas Collagen Matrix product with Secure Grip. This product helps in mitigating bleeding during bariatric surgeries. However, Asia-Pacific registering the fastest growth rate during the forecast period, according to article published in January 2020, China announced to invest $4.6 billion for construction of hospitals in Wuhan. Therefore, significant growth in number of hospitals and surgical centers is expected to support the growth of the hemostats market.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The base year of the market is 2021.

A. The global hemostats market was valued at $2,805.93 million in 2021 and is projected to reach $4,712.2 million by 2031 registering a CAGR of 5.3% from 2021 to 2031.

A. Surge in number of surgical procedures, availability of medical specialties for the treatment & management of several diseases are the upcoming trends of hemostats market in the world.

A. Orthopedic surgeries is the leading application of hemostats market.

A. North America is the largest regional market for hemostats.

A. Pfizer Inc., Teleflex Incorporated, Baxter International Inc., and Johnson & Johnson held a high market position.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Hemostats Market

Start reading instantly.
This Report and over 19,255+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2023 - Jun 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers